Marking a significant step in sustainable aquaculture nutrition, Loopworm has secured regulatory approval for the use of its insect protein and fat products as additives, attractants, and palatants in the Indian aquafeed market.
Loopworm, one of India’s leading insect biotechnology companies, has secured approval from the Coastal Aquaculture Authority (CAA) of India, certifying the direct use of Loopworm’s protein and fat products as additives, attractants, and palatants in aquaculture nutrition and health at the farm level. The company highlights this approval as showing a paradigm shift, allowing Loopworm’s products to directly serve aqua feed supplement and additive manufacturers.
The CAA approval opens an entirely new domain for Loopworm, enabling the company to bridge the gap of palatability and attractability for aquaculture feed additives products, according to the announcement. It will support farmers in challenging weather conditions and early disease incidents, as well as improve feed consumption rates for farmed fish and crustaceans, providing direct nutritional supplementation at the farm level.
The brand has started with exports of its insect protein powder (i.e, insect meal) to one of the leading global salmon feed manufacturers, making a mark in sustainable aquaculture. Multiple commercial consignments have been shipped to one of the largest clients in the salmon feed space. With this regulatory milestone, Loopworm will reportedly cater to both feed manufacturers and the broader aquaculture supplement ecosystem, expanding its addressable market in India’s growing aquaculture sector.
“This achievement reinforces our vision to create an impact in protein production through sustainable insect biotechnology,” said Ankit Alok Bagaria, Co-founder and CEO of Loopworm. “These certifications position Loopworm as a credible supplier, aligning with global pet food safety and animal feed standards. Whether it’s about dealing with pet food companies or animal feed manufacturers, these certifications highlight brand commitment in delivering safe, high-quality, and sustainable products.”
The company says it will continue to innovate beyond the traditional animal nutrition, developing applications in bio-pharmaceuticals with its affordable & quick recombinant protein production platform thereby positioning itself as a comprehensive biotech platform leveraging insect-derived biomolecules.
